# Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

> **NCT05571371** · — · UNKNOWN · sponsor: **Esraa Mostafa Ahmed Abdel Aal** · enrollment: 90 (estimated)

## Conditions studied

- Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset
- TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2
- MCP-2: Monocyte Chemo-attractant Protein-2

## Interventions

- **OTHER:** Measuring inflammatory serum biomarkers

## Key facts

- **NCT ID:** NCT05571371
- **Lead sponsor:** Esraa Mostafa Ahmed Abdel Aal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2024-10
- **Final completion:** 2024-11
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05571371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05571371, "Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05571371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*